Neurology | Clinical Neurosciences | School of Medicine | University of Utah Health Care






The University of Utah
Center for Alzheimer's Care,
Imaging and Research (CACIR)


Memory Study Line
Tel (801) 587-7888

Cognitive Disorders Clinic
Tel (801) 585-7575
Fax (801) 585-2746

Imaging & Neurosciences Center
729 Arapeen Drive
Salt Lake City, UT 84108

www.utahmemory.org
Follow us on Facebook


University of Utah Logo, linked to www.utah.edu





Research

Research Volunteers Needed for New Studies

  • Please call our Memory Study Line at 801-587-7888 for more information or to sign up.
  • We need volunteers with memory problems as well as healthy volunteers, who may be included in a study's control group.
  • If you or someone you care about is interested in helping us learn more about memory problems, our team can answer any questions you may have about clinical research studies or currently available research opportunities.

Studies Currently Enrolling

  • MK8931 in mild to moderate AD:

    A randomized, placebo controlled, parallel-group, double blind efficacy and safety trial of MK8931 in subjects with mild to moderate Alzheimer’s Disease. Volunteers must be between the ages of 55 and 85 years of age and be willing and physically able to undergo a MRI; must not have a history of any relevant neurological disorders such as, but not limited to, vascular dementia, parkinsonism, frontotemporal dementia, Huntington’s disease, etc.; must not have been diagnosed with cancer in the past five years; nor have a vitamin B12 deficiency. For more information, please contact us at 801-587-7888.
  • Solanezumab in Mild Alzheimer's Disease:

    A Phase 3, placebo-controlled study in mild Alzheimer's disease (AD) patients designed to collect data on long term safety and effectiveness of solanezumab, including cognitive outcomes, functional outcomes, quality of life, resource utilization, and biomarker measurements. Patients should be between the ages of 55 and 90, have been diagnosed with mild AD, not have had any infectious brain disease or cancer within the past five years. For more information, please contact us at 801-587-7888.

At the Forefront of Alzheimer's and Dementia Research

One of the Center's major goals is conducting research to better understand the causes of Alzheimer's disease and related memory disorders. Research at CACIR focuses on neuroimaging, clinical trials to examine the effectiveness of new drugs and treatments, and studies that examine the clinical features and pathophysiology of Alzheimer's and related memory disorders.

The Center sets itself apart from other Alzheimer's programs nationwide by implementing its research successes in the Cognitive Disorders Clinic. "We have an opportunity to develop innovative approaches to dementia care," Dr. Foster says. "I am convinced that now is the time to do this." By creating synergy between patient care and clinical research, the Center hopes to improve the standard of dementia care throughout the Intermountain West.

Using advanced imaging techniques and Utah's unique genetics resources, Foster and his colleagues are working to illuminate how specific changes in the brain correlate with differences in patient behavior. They also have shown how neuroimaging can help differentiate between Alzheimer's disease and other causes of dementia, such as frontotemporal dementia — knowledge that can help experts diagnose the cause of dementia more accurately and at earlier stages, when treatments are most effective. To learn more about neuroimaging at CACIR, click here.

Faculty Publications

To learn more about the University of Utah Alzheimer's Center, and view educational materials such as brochures and posters, please visit our Publications Gallery. To view recent scientific publications by Center faculty members, please click on the links below: